System Interventions to Achieve Early and Equitable Transplants (STEPS) Study

January 27, 2026 updated by: Wake Forest University Health Sciences
This project will study how kidney care for everyone despite race can reduce racial differences in care and improve access to kidney transplants, and specifically living donor kidney transplants (LDKT), for individuals with chronic kidney disease. A study focused on equality and patient needs (called 'STEPS') will 1) create a program to identify people who may need a kidney transplant ('STEPS Surveillance') and find people in health systems who may be able to receive kidney transplants early in their care and (2) study how well the 'STEPS Outreach' program works (comprised of transplant social workers and transplant coordinators who focus on equality and patient needs) compared to usual care to improve access to kidney transplants among Black and non-Black individuals as well as to improve access to transplants for everyone.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

1168

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27101
        • Wake Forest University Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Ability to provide oral informed consent
  • Male or female, aged 18 to <=75 years
  • Presence of CKD (2 eGFRs <60, 90 days apart) and at least 1 of the following: most recent eGFR less than 30 or KFRE greater than 10%
  • English speaking with adequate ability to hear and understand questions over the phone
  • Willing to comply with all study procedures and be available for the duration of the study

Exclusion Criteria:

  • Male or female, aged <18 or > 75 years
  • Non-English speaking
  • Lack of ability to hear and comprehend verbal communication.
  • Patients on dialysis
  • Deceased
  • Hospice/palliative care
  • Prior kidney transplant
  • Currently waitlisted at any transplant center
  • Self-reported terminal illness or receipt of hospice services

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: STEPS Health System Surveillance and Outreach intervention
STEPS Transplant Social Worker Education and Outreach, STEPS Transplant Coordinator Outreach
No Intervention: Usual Kidney Care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health system reported completion of transplant evaluation
Time Frame: 18 months
Number of patients that said "yes" to the completion of transplant evaluation as reported in health system EHR and Administrative reports
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health system reported initiation of transplant evaluation
Time Frame: 18 months
Number of patients that said "yes" to the initiation of transplant evaluation as reported in health system EHR and Administrative reports
18 months
Live donor inquires to transplant center
Time Frame: 6 months, 12 months, 18 months
the number of participants that made an inquiry to the transplant center related to live donors as reported in EHR or from questionnaire
6 months, 12 months, 18 months
Live kidney donor transplants
Time Frame: 6 months, 12 months, 18 months
The number of participants that completed their live kidney donor transplant as reported by the EHR or questionnaire
6 months, 12 months, 18 months
Placement on deceased kidney donor waitlist
Time Frame: 6 months, 12 months, 18 months
The number of patients that have been placed on the deceased kidney donor waitlist as reported in the EHR or UNOS
6 months, 12 months, 18 months
Deceased kidney donor transplants
Time Frame: 6 months, 12 months, 18 months
The number of patients that received a deceased kidney donor transplant as reported in EHR or USRDS
6 months, 12 months, 18 months
Patient reported physician discussions
Time Frame: baseline, 6 months, 12 months, 18 months
number of times patient talked to physician regarding kidney transplant measured by patient report in questionnaire
baseline, 6 months, 12 months, 18 months
Patient reported family discussions
Time Frame: baseline, 6 months, 12 months, 18 months
number of times patient talked to family regarding kidney transplant measured by patient reported in questionnaire
baseline, 6 months, 12 months, 18 months
Patient reported initiation of transplant evaluation
Time Frame: baseline, 6 months, 12 months, 18 months
Number of patients that said "yes" to the initiation of transplant evaluation measured by patient report in questionnaire
baseline, 6 months, 12 months, 18 months
Patient reported completion of transplant evaluation
Time Frame: baseline, 6 months, 12 months, 18 months
Number of patients that said "yes" to the completion of transplant evaluation measured by patient report in questionnaire
baseline, 6 months, 12 months, 18 months
Patient reported identification of a living donor
Time Frame: baseline, 6 months, 12 months, 18 months
Number of patients that said "yes" to the identification of a living donor measured by patient report in questionnaire
baseline, 6 months, 12 months, 18 months
Patient reported kidney transplant knowledge
Time Frame: baseline, 6 months, 12 months, 18 months
Number of questions patients correctly answer measured by patient report in questionnaire
baseline, 6 months, 12 months, 18 months
Patient reported empowerment
Time Frame: baseline, 6 months, 12 months, 18 months
Calculation of scaled questions from the adapted DES-SF form using a range of 1-5 for each question, with 5 being the best outcome, measured by patient report in questionnaire.
baseline, 6 months, 12 months, 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2022

Primary Completion (Actual)

December 31, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

August 13, 2021

First Submitted That Met QC Criteria

August 13, 2021

First Posted (Actual)

August 20, 2021

Study Record Updates

Last Update Posted (Actual)

January 29, 2026

Last Update Submitted That Met QC Criteria

January 27, 2026

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Diseases

Clinical Trials on STEPS Health System Outreach intervention

Subscribe